An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
Clinical Trial Grant
Awarded By
Edgewise Therapeutics, Inc.
Start Date
September 15, 2025
End Date
August 31, 2027
Awarded By
Edgewise Therapeutics, Inc.
Start Date
September 15, 2025
End Date
August 31, 2027